URINARY CRYSTAL-RENAL CELL INTERACTIONS IN UROLITHIASIS
尿石症中尿液晶体-肾细胞的相互作用
基本信息
- 批准号:2634161
- 负责人:
- 金额:$ 9.37万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1994
- 资助国家:美国
- 起止时间:1994-01-01 至 1998-12-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The candidate's long-term goal is to identify cellular and
molecular mechanisms that mediate the early events in
nephrolithiasis. The candidate and his sponsor, Dr. F. Gary
Toback, have developed an educational plan which foster acquisition
of the investigative skills and techniques necessary to conduct
state-of-the-art research in renal cell physiology, and provides
the opportunity to apply these studies directly to patients with
nephrolithiasis. Development of the candidate into an independent
investigator will be facilitated b receipt of a Clinical
Investigator Award. During the course of the proposed award, he
will expand previous collaborative efforts with established
investigators in the basic sciences at the University of Chicago,
as well as initiate new collaborations which extend his studies
into new fields. The candidate will have the unique advantage of
close contact with the University of Chicago Kidney Stone Program
and a recognized expert in nephrolithiasis. During the past 2 1/2
years the candidate has developed a tissue culture model of
nephrolithiasis and used it to characterize how renal epithelial
cells respond to an interaction with the most common crystal in
urine and stones, calcium oxalate monohydrate (COM). He found that
COM crystals adhere to the renal cell surface, undergo endocytosis,
and initiate subsequent cellular response such as early gene
expression, cytoskeletal reorganization, and DNA synthesis. A
novel observation, that Tamm-Horsfall glycoprotein (THP), the most
abundant protein in human urine, inhibits endocytosis of COM
crystals will be studied in depth because recent work reveals that
this protein appears to have lost its inhibitory function in
specific patients with recurrent nephrolithiasis. Specific aims of
the project are to: 1) Define a specific surface receptor (s) for
COM crystal on renal epithelial cells. 2) Characterize the
interaction of THP with renal epithelial cells. 3) Investigate THP
structure and function in patients with nephrolithiasis. 4) Define
factors that regulate adhesin and subsequent endocytosis of COM
crystals. 5) Identify structural and functional alteration in the
plasma membrane, cytoskeleton, and nucleus of renal epithelial
cells following attachment and endocytosis of COM crystals. 6)
Determine if adhesion and/or endocytosis of COM crystals induces
release of autocrine/paracrine factors from renal cells.
7)Identify potential therapeutic agents that block individual steps
in the cascade of cellular and molecular events set in motion when
a COM crystal interacts with a renal epithelial cell. Achieving
these specific aims will increase understanding of how kidney
epithelial cell respond to urinary crystals. Elucidation of these
processes at the cellular and molecular level could help attain the
long-term goal of formulating rational new therapeutic strategies
to prevent renal crystal retention and the formation of calculi.
候选人的长期目标是识别细胞和
调节早期事件的分子机制
肾结石。候选人和他的赞助人F·加里博士
Toback,制定了一项促进收购的教育计划
进行调查所需的调查技能和技巧
最先进的肾脏细胞生理学研究,并提供
有机会将这些研究直接应用于患有
肾结石。将候选人发展成为独立的
调查员将在收到临床报告后得到便利。
调查员奖。在提议的颁奖过程中,他
将扩大之前与已建立的合作伙伴的合作
芝加哥大学基础科学的研究人员,
以及发起新的合作来扩展他的研究
进入新的领域。候选人将拥有独特的优势:
与芝加哥大学肾结石项目密切接触
也是公认的肾结石专家。在过去的两年半内
多年来,这位候选人开发了一种组织培养模型
肾结石并用它来表征肾上皮细胞如何
细胞与细胞中最常见的晶体相互作用
尿液和结石,一水合草酸钙(COM)。他发现
COM晶体附着在肾细胞表面,经历内吞作用,
并启动后续的细胞反应,如早期基因
表达、细胞骨架重组和DNA合成。一个
新的观察,Tamm-Horsfall糖蛋白(THP),最
人尿中丰富的蛋白质,抑制COM的内吞作用
将对晶体进行深入研究,因为最近的研究表明
这种蛋白质似乎已经失去了其抑制功能
复发性肾结石的特定患者。的具体目标
本项目的目的是:1)确定一个特定的表面受体(S)
肾上皮细胞上的COM晶体。2)描述
THP与肾上皮细胞的相互作用。3)调查THP
肾结石患者的结构和功能。4)定义
调节黏附素和随后的COM内吞作用的因素
水晶。5)确定结构和功能上的变化
肾上皮细胞的质膜、细胞骨架和细胞核
COM晶体附着和内吞作用后的细胞。6)
确定COM晶体的黏附和/或内吞是否会导致
肾细胞释放自分泌/旁分泌因子。
7)确定阻碍个别步骤的潜在治疗剂
在细胞和分子事件的级联中,当
COM晶体与肾上皮细胞相互作用。实现
这些特定的目标将增加对肾脏如何
上皮细胞对尿液晶体有反应。对这些问题的解释
细胞和分子水平的过程可以帮助实现
制定合理的新治疗策略的长期目标
防止肾结晶滞留和结石的形成。
项目成果
期刊论文数量(11)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Role of calcium oxalate monohydrate crystal interactions with renal epithelial cells in the pathogenesis of nephrolithiasis: a review.
一水草酸钙晶体与肾上皮细胞相互作用在肾结石发病机制中的作用:综述。
- DOI:
- 发表时间:1996
- 期刊:
- 影响因子:0
- 作者:Lieske,JC;Hammes,MS;Toback,FG
- 通讯作者:Toback,FG
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
John C Lieske其他文献
OSTEOPONTIN AND TAMM-HORSFALL PROTEIN ARE FUNCTIONALLY SYNERGISTIC IN PREVENTING RENAL CALCIFICATION
- DOI:
10.1016/s0022-5347(08)61661-4 - 发表时间:
2008-04-01 - 期刊:
- 影响因子:
- 作者:
Lan Mo;Lucy Liaw;Andrew P Evan;Andre J Sommer;John C Lieske;Xue-Ru Wu - 通讯作者:
Xue-Ru Wu
John C Lieske的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('John C Lieske', 18)}}的其他基金
Renal macrophages in the pathogenesis of human urinary stones and Randall's plaque formation in mice
肾巨噬细胞在人类尿结石发病机制和小鼠兰德尔斑块形成中的作用
- 批准号:
10708970 - 财政年份:2022
- 资助金额:
$ 9.37万 - 项目类别:
Renal macrophages in the pathogenesis of human urinary stones and Randall's plaque formation in mice
肾巨噬细胞在人类尿结石发病机制和小鼠兰德尔斑块形成中的作用
- 批准号:
10595343 - 财政年份:2022
- 资助金额:
$ 9.37万 - 项目类别:
Improving stone disease treatment by accurate phenotyping and risk stratification
通过准确的表型分析和风险分层改善结石病的治疗
- 批准号:
9135351 - 财政年份:2013
- 资助金额:
$ 9.37万 - 项目类别:
Improving stone disease treatment by accurate phenotyping and risk stratification
通过准确的表型分析和风险分层改善结石病的治疗
- 批准号:
8598968 - 财政年份:2013
- 资助金额:
$ 9.37万 - 项目类别:
Improving stone disease treatment by accurate phenotyping and risk stratification
通过准确的表型分析和风险分层改善结石病的治疗
- 批准号:
9343372 - 财政年份:2013
- 资助金额:
$ 9.37万 - 项目类别:
相似海外基金
Discovery of cell membrane permeable HDAC6 PROTACs
细胞膜渗透性 HDAC6 PROTAC 的发现
- 批准号:
23K06061 - 财政年份:2023
- 资助金额:
$ 9.37万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Control of cell membrane permeability by intense electrical pulses and development of innovative food processing
通过强电脉冲控制细胞膜渗透性和创新食品加工的发展
- 批准号:
23H01403 - 财政年份:2023
- 资助金额:
$ 9.37万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development of a method to inhibit epithelial-mesenchymal transition by targeting cell membrane phospholipids
开发一种通过靶向细胞膜磷脂抑制上皮间质转化的方法
- 批准号:
23K06103 - 财政年份:2023
- 资助金额:
$ 9.37万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Host cell membrane perforation during invasion by Toxoplasma gondii
弓形虫入侵过程中宿主细胞膜穿孔
- 批准号:
10587658 - 财政年份:2023
- 资助金额:
$ 9.37万 - 项目类别:
Cell membrane-targeting proteoglycan chimeras as selective growth factor signaling actuators
作为选择性生长因子信号传导执行器的细胞膜靶向蛋白聚糖嵌合体
- 批准号:
10588085 - 财政年份:2023
- 资助金额:
$ 9.37万 - 项目类别:
High throughput antibody discovery against cell membrane bound target proteins using innovative MOD technology for direct screening in single-cell assays
使用创新的 MOD 技术发现针对细胞膜结合靶蛋白的高通量抗体,用于单细胞测定中的直接筛选
- 批准号:
10698891 - 财政年份:2023
- 资助金额:
$ 9.37万 - 项目类别:
Three-dimensional measurement of cell-sercreted molecules using probe-type artificial cell membrane systems
使用探针型人工细胞膜系统对细胞分泌分子进行三维测量
- 批准号:
23H01822 - 财政年份:2023
- 资助金额:
$ 9.37万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Probing the specific interactions of AlphaA- crystallin and its aging- and cataract-associated forms with lens cell membrane mimics
探讨 AlphaA-晶状体蛋白及其与衰老和白内障相关的形式与晶状体细胞膜模拟物的特定相互作用
- 批准号:
10667060 - 财政年份:2023
- 资助金额:
$ 9.37万 - 项目类别:
Nanostructure transfer to cell membrane by cytoplasmic gelation and its optical sensor application
细胞质凝胶化纳米结构转移至细胞膜及其光学传感器应用
- 批准号:
22K18760 - 财政年份:2022
- 资助金额:
$ 9.37万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
An extedned research of cell membrane domains based on the probes of membrane molecules
基于膜分子探针的细胞膜域扩展研究
- 批准号:
22H00359 - 财政年份:2022
- 资助金额:
$ 9.37万 - 项目类别:
Grant-in-Aid for Scientific Research (A)